Home > News > Spire to develop technology for orthopedic prostheses
August 12th, 2003
Spire to develop technology for orthopedic prostheses
Spire Corp. has received a two-year, $750,000 SBIR Phase II grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to develop nanotechnology coatings. Under the grant, Spire will develop hard, extremely adherent nanocrystalline coatings for orthopedic implants. The coatings contain metallic bonding and have a chemical composition very similar to the substrate. Feasibility of the technology was demonstrated during a Phase I grant.
Harris & Harris Group Notes ABSMaterials' Series B Financing November 22nd, 2013
Harris & Harris Group Letter to Shareholders on Website November 18th, 2013
Harris & Harris Group Reports Financial Statements as of September 30, 2013 November 12th, 2013
Harris & Harris Group Notes CordenPharma's Acquisition of Ancora's Carbohydrate Synthesis Platform and Corporate Name November 7th, 2013